A5081205850- Liver Disease Diagnosis and Treatment
- Inflammatory Bowel Disease
- Eosinophilic Esophagitis
- Liver Disease and Transplantation
- Liver Diseases and Immunity
- Immunodeficiency and Autoimmune Disorders
- Microscopic Colitis
- Helicobacter pylori-related gastroenterology studies
- Organ Transplantation Techniques and Outcomes
- Abdominal vascular conditions and treatments
- Dialysis and Renal Disease Management
- Dermatological and COVID-19 studies
- Turkish Literature and Culture
- Acute Kidney Injury Research
- Medical Imaging and Pathology Studies
- Body Image and Dysmorphia Studies
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- IgG4-Related and Inflammatory Diseases
- Venous Thromboembolism Diagnosis and Management
- Celiac Disease Research and Management
- Systemic Sclerosis and Related Diseases
- Cardiovascular Issues in Pregnancy
- Chronic Lymphocytic Leukemia Research
- Biosimilars and Bioanalytical Methods
- Psychosomatic Disorders and Their Treatments
Ankara University
2020-2025
Sina Hospital
2024
Gaziantep Children's Hospital
2020
Gazi University
2012
Aim: The current data have proven the pivotal role of inflammation in development atherosclerosis and cardiovascular diseases patients with chronic kidney disease (CKD). Neutrophil to lymphocyte (N/L) ratio has increasingly been reported as a measure systemic inflammation. This study assessed N/L investigated its associations standard inflammatory biomarkers different stages CKD patients. Material methods: cross-sectional included 30 predialysis, 40 hemodialysis, 35 peritoneal dialysis...
Abstract Background Inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn’s (CD), is a chronic inflammatory condition characterized by relapsing episodes. These diseases typically present with diarrhea, abdominal pain, bloody stools. However, the diagnosis of IBD may be delayed due to higher prevalence other clinical syndromes that can similar symptoms, lack using diagnostic tools or depending on patient dependent reasons. This delay exceed six month even much...
Balci, Deniz M.D.; Kirimker, Elvan Onur Bingol Kologlu, Meltem Ustuner, Evren Goktug, Ufuk Utku Karadag Erkoc, Suheyla Yilmaz, Ali Abbas Bayar, Mustafa Kemal Azap, Alpay Er, Ramazan Erdem Dokmeci, Abdulkadir Karayalcin, Kaan M.D. Author Information
<b><i>Background and Goals:</i></b> The aims of the present study were to investigate natural history cirrhosis determine trends in etiology cirrhosis. <b><i>Methods:</i></b> Between January 2001 2018, a total 1,341 patients had been diagnosed with included. <b><i>Results:</i></b> A 898 cirrhotic patients, who followed up for at least 6 months included into analysis. median age was 54 years. Child-Pugh MELD scores 7.5...
Abstract YKL‐40 has been introduced as a marker of inflammation in different clinical situations. The association between and chronic renal failure patients not researched currently. objectives this study were to establish serum concentrations dialysis with compared healthy subjects explore its relationships proinflammatory cytokine, interleukine‐6 (IL‐6) an acute phase mediator, high sensitivity C‐reactive protein (hs‐CRP). population included hemodialysis ( N = 43; mean age 40.9 ± 14.5),...
Abstract Background In the last 25 years, introduction of biological therapies has been a significant milestone in management inflammatory bowel diseases. Despite recent emergence new and small molecules, Anti-TNF agents still play crucial role treatment. number countries, anti-TNF are reimbursed as first line treatment following either failure or intolerance to conventional such thiopurines aminosalycilates. Many studies have conducted previously compare efficacy these drugs, but clear...
Abstract Background In the last 2 decades, introduction of biological therapies has been a significant milestone in management inflammatory bowel diseases. Despite recent emergence new and small molecules, Anti-TNF agents still play crucial role treatment being used as first line biologic treatments rather than anti-integrins anti-cytokines quite number countries.Although many studies have conducted previously to compare efficacy these drugs, there is not clear conclusion. this study, we...
Abstract Background After the approval of vedolizumab and ustekinumab for treatment IBD, discussions continue regarding prioritization which drug will be used as first-line treatment. Despite numerous studies in various indications on this matter, there is still no definitive information. It known that success treatments decreases after use Anti-TNF first step. In study, we aimed to compare persistence rates second-line Crohn's patients with prior experience Anti-TNF. Methods A total 171...
Sirotik hastaların %50’ye yakınında özofagus ve gastrik varisler gelişir. Varisli siroz hastalarında dekompansasyon bulgusu olarak varis kanaması görülebilmektedir. Kanamalar sıklıkla özofageal kaynaklı kanamalardır. Gastrik daha nadir kanar; ancak ciddi mortalitesi yüksek kanamalara neden olurlar. varisleri ile karşılaştırıldığında geniş çapta submukozal alanda derine uzanım gösterebilirler. Bu nedenle için yapılan standart endoskopik tedaviler büyük oranda etkisizdir. Siyanoakrilat...
In this report, we present a postmenopausal woman with “delusional disorder-somatic typeâ€, hirsutism and subclinical hypothyroidism. Blood tests revealed thyroid dysfunction high TSH anti-TPO levels but other blood radiological investments were found to be normal. The relationship between dysfunction, psychosis is discussed in the context of particular case.
Abstract Background Vedolizumab is a monoclonal antibody against integrin α4β7 that being used for the treatment of moderate to severe Ulcerative Colitis (UC) and Crohn’s Disease (CD). Recent studies have shown conflicting results effect concomitant azathioprine use with vedolizumab monotherapy. In this single center cohort study, we investigated on drug persistence in UC CD treatment. Methods We performed retrospective review all adult (≥18 years) patients started VDZ at our infusion...
Coronavirus disease-2019 has become a serious pandemic, and still remains risk despite vaccines that have been devel- oped. Among inflammatory bowel disease patients old age, activation, the existence of comorbid dis- ease, using steroids are known factors for severe coronavirus disease-2019. But there different data drugs other than corticosteroids used. The aims study to evaluate prevalence effect on disease-2019.In this among 1195 patients, 130 who were found be positive acute respiratory...